Display options
Share it on

Indian J Virol. 2010 Oct;21(2):95-102. doi: 10.1007/s13337-011-0024-5. Epub 2011 Mar 16.

Protection of Penaeus monodon from Infection of White spot syndrome virus by DNA Construct Expressing Long Hairpin-RNA Against ICP11 Gene.

Indian journal of virology : an official organ of Indian Virological Society

Rekha Das, Syamala Karthireddy, P Gireesh-Babu, A K Reddy, Gopal Krishna, Aparna Chaudhari

Affiliations

  1. Division of Fish Genetics and Biotechnology, Central Institute of Fisheries Education, Indian Council of Agricultural Research, Versova, Mumbai, Maharashtra 400061 India.

PMID: 23637487 PMCID: PMC3550717 DOI: 10.1007/s13337-011-0024-5

Abstract

A plasmid construct (pICP11-LH) was designed to constitutively express long-hairpin RNA (lhRNA) against icp11 gene, which is reportedly the most highly expressed gene of White spot syndrome virus (WSSV) and likely to have an important role in viral pathogenesis. The construct was used singly and in combination with other similar constructs designed against vp28 and vp19. A total of 6 treatments, T1 (pICP11-LH; 35 μg), T2 (pVP28-LH; 35 μg), T3 (pVP28-LH and pVP19-LH; 17.5 μg each), T4 (pVP28-LH and pVP19-LH; 25 μg:10 μg), T5 (pICP11-LH, pVP28-LH and pVP19-LH; 11.5 μg each) and T6 (pGFP-LH; 35 μg) were injected intramuscularly into 20 g Penaeus monodon specimens. The shrimp were challenged with WSSV 24 hpi and protection efficacy was measured in terms of survival and viral load 15 days after challenge. Appropriate negative and positive controls were used. T2 and T3 offered highest protection (75%) followed by T1 (67%) and T4 and T5 groups (58%), while T6 showed 25% protection. In all the target specific treatments, the viral load as estimated by single tube WSSV kit was kept in check (10-100 copies), whereas in the unimmunized challenged controls it progressed to severe infection (>10(5) copies). In spite of over 3 times higher expression of ICP11 compared to VP28, its knockdown by pICP11-LH did not offer any protective advantage over pVP28-LH, either singly or in combination. Moreover, none of the combinations bettered the protection efficacy of pVP28-LH administered alone. To investigate concerns about deleterious effect of plasmid persistence and constitutive expression on shrimp growth, a lab-scale 1 month growth study was conducted with 4 treatments T2, T3, T4 and T6, where no difference in specific growth rate was observed compared to controls.

Keywords: Combinatorial RNAi; ICP11; Long hairpin RNA; Peneaus monodon; WSSV

References

  1. Vaccine. 2009 Jun 12;27(29):3849-55 - PubMed
  2. Biochem Biophys Res Commun. 2005 Aug 19;334(1):102-7 - PubMed
  3. Nucleic Acids Res. 2004 Feb 09;32(3):893-901 - PubMed
  4. Methods. 2002 Feb;26(2):199-213 - PubMed
  5. Dis Aquat Organ. 2009 Nov 9;86(3):263-72 - PubMed
  6. Virus Res. 2005 Dec;114(1-2):133-9 - PubMed
  7. Virology. 2001 Jul 20;286(1):7-22 - PubMed
  8. Fish Shellfish Immunol. 2004 May;16(5):571-9 - PubMed
  9. J Neurosci. 2006 Jul 26;26(30):7820-5 - PubMed
  10. Dis Aquat Organ. 2005 Sep 23;66(3):265-70 - PubMed
  11. Dis Aquat Organ. 2007 Mar 13;74(3):179-89 - PubMed
  12. Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):75-86 - PubMed
  13. Biochem Biophys Res Commun. 2006 Mar 10;341(2):351-6 - PubMed
  14. J Biochem Mol Biol. 2004 Nov 30;37(6):726-34 - PubMed
  15. Fish Shellfish Immunol. 2002 Nov;13(5):391-403 - PubMed
  16. Mar Biotechnol (NY). 2008 May-Jun;10(3):242-9 - PubMed
  17. J Virol. 2004 Feb;78(4):2057-61 - PubMed
  18. Fish Shellfish Immunol. 2007 Jul;23(1):242-6 - PubMed
  19. Virology. 2005 May 25;336(1):93-9 - PubMed
  20. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20758-63 - PubMed
  21. Antiviral Res. 2005 Sep;67(3):141-6 - PubMed
  22. Mol Ther. 2007 May;15(5):878-88 - PubMed
  23. EMBO J. 2002 Nov 1;21(21):5875-85 - PubMed
  24. J Virol. 2004 Oct;78(19):10442-8 - PubMed
  25. Vaccine. 2007 Apr 12;25(15):2778-86 - PubMed
  26. Antiviral Res. 2007 May;74(2):150-5 - PubMed
  27. Mar Biotechnol (NY). 2008 Mar-Apr;10(2):198-206 - PubMed
  28. Nature. 2006 May 25;441(7092):537-41 - PubMed

Publication Types